Amyris Biotechnologies is dedicated to improving the world by leveraging breakthroughs in synthetic biology. Amyris' technology is able to provide a consistent, cost-effective supply of biofuels and other high-value natural compounds, including pharmaceuticals, fine chemicals, and nutraceuticals.

Amyris is currently focused on two major projects:

• The production of the drug artemisinin to fight malaria in developing countries
  
  
• The production of renewable biofuels to help reduce global warming